MMJ, DEA Meeting

Duane Boise stated “We are pleased with the DEA ‘s cooperation and support to facilitate our company mission to service the unmet needs of patients suffering from these chronic diseases.”

ST. PETERSBURG, Fla. (PRWEB)
April 08, 2020

Ever eager to facilitate its drug development and FDA clinical trials, MMJ International Holdings will make history by being what it claims is the first cannabis company to import highly concentrated medical marijuana extracts into the United States for clinical trial use.

The US-based company said Tuesday that it has facilitated the shipment to a specialty pharmaceutical gel cap manufacturing company for further testing and development of its proprietary formulation of MMJ-001 and MMJ-002. MMJ International Holdings is developing an oral drug product from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. MMJ will be utilizing its new product for a FDA approved clinical trials in multiple sclerosis (MS) and Huntington’s disease (HD). The US Drug Enforcement Agency’s approved MMJ to ship the compounds for its clinical trials.

Most recently MMJ International Holdings has negotiated a deal with MMJ BioPharma Cultivation,Inc who has applied for the much coveted DEA federal marijuana growers license. Under the terms of the deal, MMJ BioPharma Cultivation will be supplying pharmaceutical grade marijuana for MMJ International Holdings future pharmaceutical drug development needs. Once the medication is approved by the FDA it will be sold in pharmacies.

MMJ International Holdings also has been awarded the FDA Orphan Drug award which means that MMJ has demonstrated its promise for the diagnosis and or treatment of rare diseases or conditions. Orphan designation qualifies MMJ International Holdings for various development incentives provided by the Orphan Drug Award, including tax credits for qualified clinical testing.

As stated by MMJ’s CEO, Duane Boise, ″MMJ’s DEA approval and FDA Orphan Drug award are milestone that the company has meet as we continue to set industry standards. MMJ has established a leading position in the development of plant-derived cannabinoid therapeutics through its proven drug discovery and development processes, intellectual property portfolio and regulatory and manufacturing expertise″.

Dr. Elio Mariani, MMJ’s director of drug development stated that “MMJ International Holdings continues its process of scientific drug development and discovery by FDA protocol development processes, intellectual property portfolio and DEA regulatory manufacturing guidelines”. “We firmly believe that our MMJ natural whole plant derived molecules with a unique combination of pharmacological properties will be FDA approved as a safe and effective prescription drug that can be of great benefit in treating patients with MS and HD diseases,” .

Tim Moynahan the company chairman stated that “Patients in the MMJ International holdings clinical trials will receive gelatin capsules containing THC and CBD daily. MMJ International Holdings has several academic institutions preparing to study cannabis in Multiple Sclerosis and Huntington’s disease.” MMJ clinical trials will provide the necessary data to prove that cannabis can treat essential tremors, a neurological disorder that causes involuntary shaking. Tim Moynahan further stated that “Ultimately, there’s so much interest in THC and CBD as a treatment modality, so MMJ will be providing the clinical research data necessary to prove patient dosing, safety, and efficacy.”

In conclusion Duane Boise stated “We are pleased with the DEA ‘s cooperation and support to facilitate our company mission to service the unmet needs of patients suffering from these chronic diseases.”

Contact:

Michael Sharp

561-627-9455

SOURCE: MMJ International Holdings

Share article on social media or email:

ALEXANDRIA, Va. (PRWEB)
April 08, 2020

To minimize the occurrence of physical and digital harm in the workplace, 90 percent of organizations are training employees on safety procedures, including compliance training and programs on other topics.

Of those, 95 percent provide training for employee safety, 96 percent for workplace safety, 48 percent for customer safety, and 84 percent for digital and information safety, according to the Association for Talent Development research report Safety Training: Protecting Employees and Organizations, which is sponsored by Safety Skills.

More organizations provided safety training to employees during onboarding than at any other time (92 percent). Substantial majorities also covered safety on a regular schedule for refresher training (82 percent), in response to new government regulations (73 percent), or due to safety incidents (72 percent).

Organizations should look to the safety training required by law as the “bare minimum,” according to Elizabeth Beckham, a learning and development manager at Turner Industries, a heavy industrial construction company with more than 10,000 employees. She advises that, “Once you start doing more training than the minimum, you’re really doing more to protect your workforce and have employees buy into the culture of safety you’re building within your organization.”

Some key findings of this report are:

• A majority of organizations (71 percent) have organizational cultures that encourage safe behaviors to a high or very high extent.
• The top benefits of safety training are reducing safety incidents, cited by 88 percent of respondents, and reducing the legal liability, fines, and sanctions that occur as a result of safety incidents, cited by 56 percent of respondents.
• Some of the best practices associated with being a highly safe organization—one that has a culture that encourages safety and performs better on safety than other organizations in its industry—include providing more safety training than the law requires, incorporating simulations into safety training, holding daily safety meetings, and training all managers on safety-related topics.

Three in four organizations (75 percent) delivered safety training using simulations. Of those, 73 percent used non-tech-based simulations (such as fire drills or role playing), 70 percent used computer-based simulations (for example, simulated phishing attacks), and 27 percent used virtual or augmented reality simulations.

United Parcel Service (UPS) incorporates virtual reality simulations into its safety training for delivery drivers. At training centers in the United States and Europe, its future delivery drivers wear headsets that immerse them in digitally recreated streets, rife with road hazards. The drivers must prove that they can verbally identify hazards in the simulation before they can begin more intensive on-road training.

A free webcast on the findings in Safety Training: Protecting Employees and Organizations is scheduled for April 22 at 2 p.m.

About ATD

The Association for Talent Development (ATD) is the world’s largest professional membership organization supporting those who develop the knowledge and skills of employees, improve performance, and help to achieve results for the organizations they serve. Originally established in 1943, the association was previously known as the American Society for Training & Development (ASTD).

ATD’s members come from more than 120 countries and work in public and private organizations in every industry sector. ATD supports talent development professionals who gather locally in volunteer-led U.S. chapters and international member networks and with international strategic partners.

For more information, visit td.org.

Share article on social media or email:

PLEASANTON, Calif. (PRWEB)
April 07, 2020

Tri-Valley companies are flattening the curve and fighting the pandemic that is affecting us all on a global scale.

#TRIVALLEYtogether highlights some of the region’s most immediate needs and calls on the broad business community and public to take action. With increased global shortages of supplies, Tri-Valley health care providers and educators are gratefully accepting donations of needed supplies from the community. CLICK HERE for more information.

“It’s great to see the Tri-Valley leverage its awesome power as an innovation hub, as well as its leadership and generosity, to help our communities weather this terrible storm,” Congressman Eric Swalwell said. “We are stronger together than apart, and together we will get through this.”

The Tri-Valley’s technology assets are the engine for the region’s economic strength. Lawrence Livermore National Laboratory, Sandia National Laboratories, several regional hospitals and dozens of life science companies like Roche Molecular Solutions and DeltaTrak are generating innovations to battle the virus every day.

“#TRIVALLEYtogether targets 3 sectors that need our support right away,” said Steve Lanza, Vice President of Lam Research and Chair of Innovation Tri-Valley Leadership Group (ITV). “With so many in need, we are hopeful everyone can find a way to contribute. We are calling on our innovative community of thinkers and doers in the Tri-Valley to step up right now to make a huge impact together. Given the diversity of need, we are encouraging those who can to find a path to help.” ITV welcomes businesses all across the San Francisco East Bay region to join this effort using innovation, empathy and connectivity to build regional resiliency.

#TRIVALLEYtogether invites donations of technology to support online learning, medical supplies to TRIVALLEY Hospitals and medical centers, and cash to support the region’s most vulnerable homeless population. CLICK HERE for more information.

Join Innovation TRIVALLEY Leadership Group (ITV) by spreading the word, donating, or simply supporting your local businesses as we navigate this time of uncertainly together. CLICK HERE for more information to find your way to help.

MORE RESOURCES:

For Volunteer and Donation Opportunities in your local TRIVALLEY community:

Town of Danville – For Town resources CLICK HERE

Danville Chamber Updates CLICK HERE

City of Dublin – For information on City resources CLICK HERE

City of Dublin Resource Guide CLICK HERE

City of Livermore – For information on City resources CLICK HERE

Unify Livermore Community Support Information CLICK HERE

Livermore Chamber Updates CLICK HERE

City of Pleasanton – For information on City resources CLICK HERE

Pleasanton Donation Information CLICK HERE

City of San Ramon – For information on City resources CLICK HERE

Contra Costa Community Donation Information CLICK HERE

ABOUT Innovation Tri-Valley Leadership Group

Innovation Tri-Valley Leadership Group (ITV) is a collective of leaders and influencers committed to connecting the businesses, educational institutions, research labs, and civic leaders in the Tri-Valley region. ITV showcases the region as a technology and innovation powerhouse, outpacing the Bay Area mega-region in both job creation and economic growth. The Tri-Valley today is home to more than 450 technology companies and the regional innovation economy drives a $42 billion GDP.

Share article on social media or email:

DENVER (PRWEB)
April 07, 2020

With water and wastewater critical to fighting the coronavirus (COVID-19) pandemic, water utilities are swiftly employing plans to prevent service disruptions and assist households struggling to pay water bills, according to a recent survey conducted by the American Water Works Association (AWWA).

Ninety-seven percent of the 532 responding utilities have measures in place or in development to keep essential field workers on the job. Ninety-five percent of the responses indicate they are assessing options for staff shift change policies to incorporate social distancing at the workplace.

The two most pressing challenges reported by utilities are social distancing of workforce and supply chain issues for personal protective equipment (PPE). Nearly 40 percent of utilities reported disruptions in the supply chain for PPE, and nearly three quarters are expecting disruptions in the future.

Conducted online from March 25-30, this marks the second in a series of surveys of how AWWA member organizations are adapting to impacts from the COVID-19 pandemic. The second survey of AWWA member organizations generated 615 responses, including from 532 different utilities and 81 non-utility responses (consultants, manufacturers, service providers and others). The responses offer a near real-time assessment of how water sector organizations are currently managing risks of the COVID-19 pandemic.

To assist customers impacted by the economic fallout of COVID-19, more than 90 percent of responding utilities have suspended water shut-offs and about 67 percent are waiving late fees. Additionally, some utilities indicate they are providing payment plan options, waiving charges like service fees, and a few are considering rate reductions or forgiving payments for one billing cycle.

The survey also showed utilities are concerned about potential revenue challenges, with 64 percent of utilities expecting financial implications in the coming months and about 10 percent are already seeing revenue reductions. AWWA and other water sector organizations are advocating for the inclusion of water sector funding in future stimulus bills.

Sixty-seven percent of utilities reported that they have business continuity plans in place, and another 20 percent are currently developing them. AWWA is encouraging utilities to take advantage of Business Continuity Planning for Water Utilities: Guidance Document (AWWA, Water Research Foundation, U.S. EPA, 2013) in assessing their plans.

AWWA is offering resources to assist utilities with dealing with the challenges that arise during the pandemic at awwa.org/coronavirus.

Established in 1881, the American Water Works Association is the largest nonprofit, scientific and educational association dedicated to managing and treating water, the world’s most important resource. With approximately 51,000 members, AWWA provides solutions to improve public health, protect the environment, strengthen the economy and enhance our quality of life.

Share article on social media or email:

BOCA RATON, Fla. (PRWEB)
April 07, 2020

West Boca Eye Center Adapts to COVID-19 Pandemic Protocols to Safely Provide Urgent & Emergent Care

The Coronavirus pandemic means health care providers are adopting radical precautions while treating patients. In accordance with the CDC and WHO, the West Boca Eye Center has ceased all procedures except those of an urgent or emergency nature. Brent Bellotte MD. explains how they’re providing for the welfare of patients and staff alike.

The provision of impeccable infection control is something the West Boca Eye Center prides themselves upon at all times. Never has this been more crucial than right now, and one of the biggest issues for the ophthalmology industry is that it involves up-close work with an area of the body that presents a high-risk portal of entry for the virus to infect the body—the eyes.

Following in-depth collaborations with major subspecialty societies, lead clinician at the clinic, Brent Bellotte MD. has put in place strict guidelines regarding treatment provided to their patients. This has been done to ensure the safety of both staff and patients in this time of unprecedented risk.

COVID-19 Specific Precautions in Place at the West Boca Eye Center

With immediate effect, the clinic has ceased the provision of all ophthalmology care that doesn’t fall into emergency or urgent categories. Initial consultations will take place via telephone and/or video consultation. Following this, those deemed in need of urgent or emergency attention will be asked a range of questions to determine their risk of having been exposed to the virus. These include, but aren’t limited to, asking about any of the common symptoms of COVID-19—fever, cough, or other respiratory issues—as well as recent travel (in the past 14 days) to a country or US region with high numbers of infected cases.

Should the patient answer yes to one or more of these they will immediately be directed to their primary care physician. Patients deemed appropriate for treatment within the clinic will be invited for an appointment. Social distancing of at least 6 feet will be strictly adhered to, with patients requested not to arrive before their allotted appointment time to ensure the waiting area is kept as clear as possible. Those who’ve been determined as the most vulnerable due to age and/or health conditions will only be requested to attend the clinic if absolutely necessary.

Safety during individual treatment

All areas and equipment will be thoroughly cleaned and disinfected between each patient to reduce contamination risk as much as possible. When invited to enter the treatment room patients will be requested to speak as little as possible during the procedure—a practice that the clinician will also adhere to. Anyone who is coughing, sneezing, or has any flu-like symptoms will be requested to wear a mask during their eye examination. Breath shields and slit-lamp barriers may also be in place to further shield against infection.

Any patients with respiratory illness symptoms but without any COVID-19 risk factors will be treated by a clinician wearing gloves, gowns, surgical masks, and eye protection. The clinician may wear an N-95 mask should the treatment necessitate. The examination room will be thoroughly disinfected after each patient.

As always, the safety of the patients and staff is of the utmost priority. With the pandemic presenting an evolving situation, Brent Bellotte MD. and his clinical team are in constant communication with the CDC, WHO, and the American Board of Ophthalmology to ensure the West Boca Eye Centre adheres to the very latest safety standards.

Anyone requiring urgent treatment or advice on their eye condition or ongoing care is requested to make contact by phone or email in the first instance. Further details about the clinic can be found at https://westbocaeyecenter.com.

Share article on social media or email: